SyncoZymes

litaba

Litaba tse monate: Syncozymes e ananetsoe e le projeke ea phetoho ea katleho ea theknoloji e phahameng

Ka la 5 Pherekhong 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. e ile ea fuoa "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.

Jwalo ka kgwebo ya naha ya theknoloji e phahameng, Suntech Biotech e dula e nka biotechnology ho etella pele ntshetsopele ya indasteri ya dikhemikhale le meriana, mme e tlisa botala le bophelo bo botle ho batho e le sepheo sa yona. Ho hodisa kgwebo ka ditsela tse ngata, ho sebelisana ka mafolofolo le dikolo le dikgwebo tse tsebahalang lapeng le kantle ho naha, ho ntshetsa pele bokgoni ba yona ba ntshetsopele kamehla, ho ntlafatsa sebopeho sa ka hare sa kgwebo, le ho ba betere le ho ba matla.

katleho ea theknoloji e phahameng

Lebitso la projeke: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
Nomoro ea Ntho: 202010694
Boemo ba ntho: B
Hore na ho na le lintho tse finyeletsoeng lefapheng la theknoloji e phahameng ka litokelo tse ikemetseng tsa thepa ea kelello: E

Tšebeliso: (S)-1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) ke sesebelisoa sa bohlokoa sa chiral bakeng sa ho kopanya li-API tsa ibrutinib. Ibrutinib ke moriana o mocha oa anticancer o shebaneng le mofetše oa lisele tsa B o ileng oa amoheloa tlas'a tumello e potlakileng ke US Food and Drug Administration (FDA) ka la 13 Pulungoana 2013 bakeng sa kalafo ea lymphoma.

Tlhaloso ea phetoho ea katleho ea theknoloji e phahameng
Phetoho ea liphihlello tsa theknoloji e phahameng e bolela ts'ebetso eo likhoebo li etsang tlhahiso le ts'ebetso ea theknoloji e phahameng ho eona. Mmuso o tšehetsa likhoebo ho kenya tšebetsong phetoho ea liphihlello tsa saense le theknoloji ka lipatlisiso le nts'etsopele e ikemetseng, ho fana ka lilaesense, ho nka likarolo ka theko, le ho sebelisana le liindasteri, liunivesithi le litsi tsa lipatlisiso. Bakeng sa merero ea phetoho ea phihlello ea theknoloji e phahameng e hlahlojoang le ho tlalehoa ke khoebo, ho latela ho phethoa ha matšoao a eona a moruo a felletseng le litšobotsi tsa litokelo tsa thepa ea kelello ea projeke, tekanyo ea boqapi, jj., matsete a eona a R&D a amana le litokelo tsa thepa ea kelello tse amanang le projeke, litifikeiti tsa patent ea boqapi, kapa tse kenang mohatong oa tlhahlobo ea bohlokoa. Setifikeiti sa tlhompho se fuoang khoebo kamora tlhahlobo e tiileng le lipatlisiso tse tebileng tsa 'maraka, joalo ka lisebelisoa tsa bopaki tsa kopo ea patent ea boqapi, setifikeiti sa patent ea mohlala oa utility, setifikeiti sa ngoliso ea litokelo tsa moqapi oa software, setifikeiti sa ngoliso ea moralo oa potoloho e kopaneng, jj.

Boemo ba Khoebo
Shangke Biomedical (Shanghai) Co., Ltd. e thehiloe ka 2008 mme e fumaneha International Medical Park, sebaka se ka boroa sa Zhangjiang Hi-Tech Park, Pudong, Shanghai. Ke lekala le felletseng la Zhejiang Shangke Biomedical Co., Ltd. Shangke Bio e ikemiselitse ho etsa lipatlisiso le nts'etsopele ea tšimo ea meriana e tala e tsoetseng pele ka ho fetisisa, e etella pele nts'etsopele ea indasteri ea meriana ea lik'hemik'hale ka biotechnology e tala, 'me e fana ka lihlahisoa tse ncha le lits'ebeletso tsa boleng bo holimo bakeng sa indasteri ea meriana. Ke khoebo ea theknoloji e phahameng Shanghai hape ke khoebo ea theknoloji e phahameng ea Shanghai "E ikhethileng, e ntlafalitsoeng, e khethehileng le e ncha".

Kgwebo e ka sehloohong ya Suntech e kenyeletsa: ntshetsopele le tshebediso ya dienzyme tsa baeloji, ntshetsopele le tlhahiso ya di-intermediate tsa meriana, di-API le dikhemikhale tse sebetsang. Dihlahiswa tse ka sehloohong tsa khamphani ke dihlahiswa tsa coenzyme, ho kenyeletswa NMN, NAD, NADP, NADH, NADPH, dienzyme tsa baeloji, thepa e tala ya meriana le di-intermediate. Bareki le balekane ba khamphani ba lefatsheng ka bophara, mme e thehile dikamano tse haufi tsa tshebedisano mmoho le dikhamphani tse ngata tsa meriana Amerika Leboya, Europe, India le China.


Nako ea poso: Pherekhong-15-2021